ECL Ecolab, Inc.

XNYS 288.77 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ECL $288.77 —
Key stats
$288.77
52-Week Range
$243.15 – $309.27
YTD
+9.95%
IV Rank (30D)
71.9
Straddle Price
$20.10
P/C Vol Ratio
0.82
Market Cap
$81.5B
Open
$292.28
Day Range
$286.00 – $294.29
Volume
3,401,367
Prev Close
$290.81
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.21%
Beta vs SPY0.97
Cost of Equity (CAPM)10.07% (VRP-adj)
WACC9.50%
Volatility Risk Premium+28.3pp (IV − HV30)
Effective Tax Rate18.9%
Rev. Growth (YoY, DCF input)+6.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.06 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$1.9B
Return on Equity (TTM)21.1%
Book / Price12.2%
Gross Margin (TTM)44.1%
FCF Margin (TTM)11.1%
Debt / Equity1.18
Quality Score2/6 — normal (10y DCF)
Market-Implied Growth+23.2% (reverse-DCF on current price)
SMA 50$279.62 (Market Anchor value)
SMA 20 / Bollinger Mid$278.64
Bollinger Width / SMA202.9% (drives anchor stability)
Net Debt$6.8B
Market Cap$83B
Peers used for multiples: AWK, FCX, FERG, LIN, NEM, NVDA, VLTO, XYL
60-Day Conviction
36%
20-Day Fair Value
≈ by Nov 16, 2026
$293.46
α +1.6% rank 6%
conviction
80%
40-Day Fair Value
≈ by Dec 15, 2026
$296.10
α +2.5% rank 8%
conviction
72%
60-Day Fair Value
≈ by Jan 13, 2027
$291.38
α +0.9% rank 8%
conviction
36%
MethodImplied PriceWeightDetail
DCF $94.72 19%
DDM (Gordon) $60.46 0%
Peer P/E $191.13 9% median 24.2× · 8 peers
Peer EV/EBITDA $168.85 9% median 13.9× · 8 peers
Peer P/B $191.31 2% median 5.4× · 8 peers
Peer P/S $278.71 6% median 4.4× · 8 peers
Market Anchor (SMA50) $279.62 38% stability 100% (BB-width)
Options Expected (B-L 30d) $290.56 19% 23 strikes · skew -1.27
As of 2026-10-16 · updated
About
Industry (SIC)
SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS (2840) · industry map
Exchange
XNYS
Market Cap
$81.5B
Employees
48,000
List Date
1972-06-01
CIK
0000031462
Next Earnings
2026-10-27 (Pre-Market)
EPS Forecast
$2.18 (9 est.)
Headquarters
Saint Paul, MN
Homepage
https://www.ecolab.com

Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, data center, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management and cooling solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Month'21'22'23'24'25'26Avg
Jan-4.57%-17.57%5.18%0.01%8.34%7.37%-0.21%
Feb0.45%-8.04%2.34%12.40%7.82%8.71%3.95%
Mar1.35%3.55%4.42%2.39%-6.04%-12.34%-1.11%
Apr3.35%-6.12%1.10%-0.78%-1.12%-3.32%-1.15%
May-5.23%-1.03%-2.21%3.21%5.15%-1.35%-0.24%
Jun-4.25%-5.59%10.39%2.18%1.62%11.23%2.60%
Jul5.57%4.76%-1.84%-2.04%-3.98%-0.56%0.32%
Aug3.34%-1.93%-0.73%5.39%6.14%1.35%2.26%
Sep-7.27%-11.07%-7.28%2.98%-0.34%-2.02%-4.17%
Oct4.01%5.32%0.50%-3.08%-4.93%6.50%*1.39%
Nov-0.47%4.79%14.66%1.72%6.88%--5.52%
Dec6.49%-4.20%3.09%-5.69%-3.79%---0.82%
Total1.61%-33.49%31.66%19.05%15.15%14.15%8.02%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $279.62
SMA 50: $279.73
SMA 200: $274.82
Current: $288.89
EMA 12: $283.65
EMA 26: $280.76
MACD: 2.8935 | Signal: 1.5204
BULLISH
ADX (14): 18.44
RANGE
+DI: 30.44
−DI: 16.58

Momentum Oscillators

RSI (14): 63.36
NEUTRAL
Stoch %K: 84.80
Stoch %D: 90.01
Williams %R: -24.78

Volume & Volatility

BB Upper: $290.74
BB Lower: $268.49
NEUTRAL
OBV: 29,838,497
Vol SMA 20: 1,263,119
Vol ROC: 177.84%
ATR: $5.55
True Range: $8.29
HV 20: 15.8%
HV 30: 16.2%
HV 60: 18.7%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-18T00:00:00 – 2026-10-16T00:00:00
AI Analysis

LLM Stock Analysis Report - ECL

Executive Summary

Overall assessment: NEUTRAL (6/10)

Key drivers:

  • Strong technical momentum with MACD signal line crossover
  • Low volatility and beta relative to market
  • Positive recent news sentiment with earnings beats and product launches

Primary risks:

  • Overbought RSI and Stochastic %K levels, indicating potential for short-term correction
  • Market may react negatively to regulatory changes or management shake-ups

Investment thesis: ECL's technical momentum and low volatility make it an attractive stock in a range-bound market. While there are some cautionary signs from the recent news headlines, overall sentiment remains positive.

Recent news sentiment impact: The majority of recent news headlines have been positive, with earnings beats, product launches, and sector performance driving investor optimism. The neutral sentiment of the CEO appointment and global medical device cleaning market growth stories did not significantly impact the stock's price movement.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Bullish, Medium-term (1-3 months): Neutral, Long-term (3-12 months): Bullish

Support/Resistance Levels: Key price levels include:

  • Upper Bollinger Band: $286.09
  • Middle Line: $273.76
  • Lower Bollinger Band: $261.43
  • Trend line support: $268.45

Momentum Signals:

  • RSI interpretation: Overbought (>70) at 55.03, indicating potential for short-term correction.
  • MACD signal: Bullish crossover with a reading of 1.94 / Signal: 0.72 / Histogram: 1.22
  • Bollinger Bands position: Neutral squeeze

Volume Analysis: Volume trends and institutional interest signals:

  • Volume SMA 20: 1194461.65, indicating low volume
  • On-Balance Volume (OBV): 42665138.94, suggesting accumulation
  • Volume Rate of Change: 38.69%, indicating moderate buying pressure

News & Sentiment Analysis

Recent Headlines Summary: Key themes include:

  • Earnings beats and product launches driving investor optimism
  • Sector performance and market commentary supporting the stock's price movement

Sentiment Assessment: Aggregate news sentiment is positive (6/10), with a focus on earnings, products, and sector performance.

Catalyst Identification: Upcoming events that may impact the stock include:

  • Earnings announcements
  • Regulatory changes affecting the medical device industry
  • Product launches or updates

Market Narrative: The recent news headlines align with the technical signals, supporting the bullish trend. However, there are some cautionary signs from the overbought RSI levels and sector performance.

Risk & Volatility Assessment

Beta Interpretation: Low risk relative to market (beta 0.51)

Volatility Regime: Current volatility is low, with a stock volatility of 0.22

Options Market Signals:

  • IV Rank: 36.1% (Medium), indicating historically average volatility
  • Current IV: 53.4%
  • Expected Move: $13.55 (21 DTE)
  • Volume Flow: 421 calls vs 412 puts, suggesting neutral sentiment
  • Open Interest: 2,487 calls vs 3,169 puts, indicating moderate buying pressure

Downside Protection: Support levels include:

  • Trend line support: $268.45
  • Lower Bollinger Band: $261.43

Market Context & Positioning

Sector Performance: Relative strength within the sector is positive.

Institutional Activity: Volume patterns suggest institutional interest and buying pressure.

Correlation Analysis: The stock moves in tandem with the market (R-squared 0.30), indicating a low-risk profile.

Relative Valuation: The stock trades within its historical range, with a relatively low beta and volatility.

Key Levels & Action Items

Critical Price Levels:

  • Upper Bollinger Band: $286.09
  • Middle Line: $273.76
  • Lower Bollinger Band: $261.43
  • Trend line support: $268.45

Breakout/Breakdown Levels: Technical levels that could trigger significant moves include:

  • Resistance at the upper Bollinger Band: $286.09
  • Support at the lower Bollinger Band: $261.43

Time-Sensitive Catalysts: Upcoming events that may impact the stock's price movement include:

  • Earnings announcements
  • Regulatory changes affecting the medical device industry
  • Product launches or updates

Risk Management: Stop-loss levels and position sizing considerations include:

  • Risk-reward ratio of 3:1 or higher
  • Position size adjusted based on risk tolerance and market volatility
  • Stop-loss triggered at key price levels (support/resistance)
Generated
Earnings History
17 of 22 under expected move
Avg Expected Move
5.31%
Avg Actual Move
3.74%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-04-27 Pre-Market 5.27% 3.70% 0.70x Within
2021-07-27 Pre-Market 4.74% 0.76% 0.16x Within
2021-10-26 Pre-Market 4.60% 3.94% 0.86x Within
2022-01-20 Pre-Market 6.47% 0.76% 0.12x Within
2022-03-30 Pre-Market 4.25% 1.26% 0.30x Within
2022-07-26 Pre-Market 7.20% 2.70% 0.38x Within
2022-11-01 Pre-Market 7.44% 8.97% 1.21x Exceeded
2023-02-14 Pre-Market 4.64% 7.11% 1.53x Exceeded
2023-04-05 Pre-Market 4.05% 0.75% 0.19x Within
2023-08-01 Pre-Market 5.19% 1.11% 0.21x Within
2023-10-31 Pre-Market 5.72% 5.40% 0.94x Within
2024-02-13 Pre-Market 4.33% 8.97% 2.07x Exceeded
2024-04-30 Pre-Market 4.94% 2.02% 0.41x Within
2024-07-30 Pre-Market 5.02% 7.69% 1.53x Exceeded
2024-10-29 Pre-Market 5.67% 1.05% 0.19x Within
2025-02-11 Pre-Market 5.12% 6.22% 1.21x Exceeded
2025-04-29 Pre-Market 5.44% 3.30% 0.61x Within
2025-07-29 Pre-Market 4.69% 3.93% 0.84x Within
2025-10-28 Pre-Market 5.24% 4.09% 0.78x Within
2026-02-10 Pre-Market 4.72% 3.98% 0.84x Within
2026-04-28 Pre-Market 5.43% 0.34% 0.06x Within
2026-07-28 Pre-Market 6.61% 4.24% 0.64x Within

Earnings calendar: this week’s reports with expected vs actual moves →

ECL Options Activity & IV Rank

ECL IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 28.0%
7-DTE IV: —
Expected Move: $20.10
7-DTE Move: $2.97
Days to Exp: 35 (2026-11-20)

Options Flow

Call Volume: 2,284
Put Volume: 1,873
P/C Volume: 0.82
NEUTRAL
Call OI: 1,440
Put OI: 516
P/C OI: 0.358
Total OI: 1,956

ATM Options Pricing

ATM Call: $9.50
ATM Put: $10.60
Call %: 3.3%
Put %: 3.7%

Chain Summary

Chain Volume: 9,955
Chain OI: 20,066
Last Updated: 10/16/2026
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 82nd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
82%
vs own history
GEX tilt
+0.74
OI-weighted, today
Vanna tilt
+0.41
δ-sensitivity to IV
Charm tilt
-0.65
δ-decay vs time
Vanna tilt +0.41: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.65: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 39 ATM contracts, 7k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
ATM 28.0% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)71.9MediumOct 16
Straddle Price (30 DTE)$20.10Oct 16
Beta Analysis

Risk Metrics

Beta: 0.5000
Alpha: 1.27%
Correlation: 0.2921
R-Squared: 8.5%
Stock Volatility: 21.8%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ECL
7 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Cascade Investment Family office
Bill Gates
$8.76B
23.81%
#2 of 3—Form 4 · 10% owner
Gates Foundation Trust Foundation
Bill Gates
$1.45B
4.22%
#6 of 240.0%13F
Citadel Hedge fund
Ken Griffin
$294.4M
0.17%
#105 of 6285+534.0%13F
Markel Group Holding company
Tom Gayner
$76.4M
0.58%
#49 of 1300.0%13F
Point72 Hedge fund
Steve Cohen
$51.9M
0.08%
#317 of 1945new13F
Millennium Management Hedge fund
Izzy Englander
$48.0M
0.03%
#641 of 3716+31.5%13F
Rockefeller Capital Management Family office
Rockefeller family
$39.4M
0.06%
#296 of 4729+9.8%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

ECL Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 284,125,000 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

1,781 filers253,775,341 shares$70.21B value89.32% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 25,327,693 $6.65B 9.47% 8.91% 2025-12-31
2 BlackRock, Inc. Custodian 23,051,363 $6.42B 9.15% 8.11% 2026-06-30
3 Vanguard Capital Management LLC 16,537,270 $4.61B 6.56% 5.82% 2026-06-30
4 JPMorgan Chase & Co Custodian 14,619,468 $4.07B 5.80% 5.15% 2026-06-30
5 State Street Corp 11,770,714 $3.29B 4.68% 4.14% 2026-06-30
6 Morgan Stanley Custodian 7,827,291 $2.18B 3.11% 2.75% 2026-06-30
7 Vanguard Portfolio Management LLC 6,300,975 $1.76B 2.50% 2.22% 2026-06-30
8 Geode Capital Management, LLC Custodian 5,996,032 $1.69B 2.41% 2.11% 2026-06-30
9 GATES FOUNDATION TRUST 5,218,044 $1.45B 2.07% 1.84% 2026-06-30
10 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Custodian 3,617,425 $1.01B 1.44% 1.27% 2026-06-30
11 Royal Bank of Canada Custodian 3,611,647 $1.01B 1.43% 1.27% 2026-06-30
12 Aristotle Capital Management, LLC 3,516,811 $979.84M 1.40% 1.24% 2026-06-30
13 Norges Bank 3,350,825 $933.57M 1.33% 1.18% 2026-06-30
14 Capital Research Global Investors 2,863,333 $797.75M 1.14% 1.01% 2026-06-30
15 Northern Trust Corp Custodian 2,729,870 $760.57M 1.08% 0.96% 2026-06-30
16 Invesco Ltd. Custodian 2,711,224 $755.37M 1.08% 0.95% 2026-06-30
17 Franklin Resources, Inc. Custodian 2,510,305 $699.40M 1.00% 0.88% 2026-06-30
18 Pictet Asset Management Holding SA 2,501,585 $696.97M 0.99% 0.88% 2026-06-30
19 Arrowstreet Capital, Limited Partnership 2,293,546 $639.00M 0.91% 0.81% 2026-06-30
20 Charles Schwab Investment Management, Inc. 2,249,728 $626.80M 0.89% 0.79% 2026-06-30
21 Amundi Custodian 2,148,483 $598.53M 0.85% 0.76% 2026-06-30
22 Bank of America Corp Custodian 2,077,898 $578.92M 0.82% 0.73% 2026-06-30
23 Goldman Sachs Group Inc Custodian 1,944,814 $541.84M 0.77% 0.68% 2026-06-30
24 Nordea Investment Management AB 1,792,656 $499.25M 0.71% 0.63% 2026-06-30
25 Legal & General Group Plc Custodian 1,777,070 $495.11M 0.71% 0.63% 2026-06-30
16 filers$176.17M notional
# Filer Notional Value % of Total Period
1 Jane Street Group, LLC Custodian $53.24M 30.22% 2026-06-30
2 Susquehanna International Group, LLP Custodian $50.48M 28.66% 2026-06-30
3 Millennium Management LLC Custodian $15.99M 9.08% 2026-06-30
4 IMC-Chicago, LLC Custodian $14.49M 8.22% 2026-06-30
5 Citadel Advisors LLC Custodian $12.43M 7.05% 2026-06-30
6 Allianz Asset Management GmbH $6.97M 3.95% 2026-06-30
7 Simplex Trading, LLC Custodian $6.66M 3.78% 2026-06-30
8 Wolverine Trading, LLC Custodian $3.55M 2.01% 2025-09-30
9 GROUP ONE TRADING LLC Custodian $3.15M 1.79% 2026-06-30
10 Walleye Trading LLC $2.84M 1.61% 2026-06-30
11 Twin Tree Management, LP $2.73M 1.55% 2026-06-30
12 PEAK6 LLC $1.37M 0.77% 2026-06-30
13 Point72 Asset Management, L.P. $1.00M 0.57% 2026-06-30
14 Walleye Capital LLC $668.66K 0.38% 2026-06-30
15 Squarepoint Ops LLC $417.92K 0.24% 2026-06-30
16 JPMorgan Chase & Co Custodian $195.02K 0.11% 2026-06-30
21 filers$169.73M notional
# Filer Notional Value % of Total Period
1 Oribel Capital Management, LP $44.47M 26.20% 2026-06-30
2 Citadel Advisors LLC Custodian $31.82M 18.75% 2026-06-30
3 Jane Street Group, LLC Custodian $23.15M 13.64% 2026-06-30
4 IMC-Chicago, LLC Custodian $17.19M 10.13% 2026-06-30
5 Susquehanna International Group, LLP Custodian $11.90M 7.01% 2026-06-30
6 Allianz Asset Management GmbH $8.30M 4.89% 2026-06-30
7 Twin Tree Management, LP $6.52M 3.84% 2026-06-30
8 BOOTHBAY FUND MANAGEMENT, LLC $4.57M 2.69% 2026-06-30
9 Wolverine Trading, LLC Custodian $4.15M 2.44% 2025-09-30
10 Walleye Trading LLC $3.65M 2.15% 2026-06-30
11 PEAK6 LLC $3.62M 2.13% 2026-06-30
12 Simplex Trading, LLC Custodian $2.67M 1.58% 2026-06-30
13 Lido Advisors, LLC $1.67M 0.98% 2026-06-30
14 Millennium Management LLC Custodian $1.50M 0.89% 2026-06-30
15 Walleye Capital LLC $1.31M 0.77% 2026-06-30
16 Point72 Asset Management, L.P. $863.69K 0.51% 2026-06-30
17 UBS Group AG Custodian $835.83K 0.49% 2026-06-30
18 Squarepoint Ops LLC $807.97K 0.48% 2026-06-30
19 TUDOR INVESTMENT CORP ET AL $362.19K 0.21% 2026-06-30
20 Capula Management Ltd $195.03K 0.11% 2026-06-30
21 Cerity Partners LLC Custodian $167.17K 0.10% 2026-06-30

ECL Insider Trading (Form 4)

Latest: 2026-10-02
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-02 Lionel L Nowell III Director Award (A) +131 — EDGAR
2026-10-02 Michael Larson Director Award (A) +131 — EDGAR
2026-10-02 Marion K. Gross Director Award (A) +131 — EDGAR
2026-10-02 John J Zillmer Director Award (A) +131 — EDGAR
2026-10-02 Julie Whalen Director Award (A) +131 — EDGAR
2026-10-02 David MacLennan Director Award (A) +177 $276.36 $12.8K EDGAR
2026-10-02 Judson Althoff Director Award (A) +131 — EDGAR
2026-10-02 Suzanne M Vautrinot Director Award (A) +131 — EDGAR
2026-10-02 Michel D Doukeris Director Award (A) +131 — EDGAR
2026-10-02 Eric Mark Green Director Award (A) +275 $276.36 $40.0K EDGAR
2026-10-02 Shari L Ballard Director Award (A) +262 $276.36 $36.3K EDGAR
2026-10-02 Tracy B McKibben Director Award (A) +131 — EDGAR
2026-09-14 Eric Mark Green Director Buy (P) +3,690 $276.64 $1.02M EDGAR
2026-08-20 Christophe Beck CHAIRMAN, PRESIDENT & CEO Sell (S) −17,862 $280.14 -$5.00M EDGAR
2026-08-11 Gregory B Cook Co-COO - Global Businesses Sell (S) −4,567 $285.13 -$1.30M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

ECL Insider Holdings

31 insiders · @ $288.89
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 CASCADE INVESTMENT, L.L.C. 10%+ Owner 30,326,627 $8.76B -$46.08M 7 2024-11-08
2 William H Gates III 10%+ Owner 29,248,741 $8.45B $682.84M 20 2024-11-22
3 Christophe Beck CHAIRMAN, PRESIDENT & CEO 74,687 $21.58M -$43.37M 47 2026-08-20
4 John J Zillmer Director 49,540 $14.31M $0 109 2026-10-02
5 Darrell R Brown Co-COO - Global Markets 42,733 $12.35M -$13.07M 26 2026-06-10
6 Arthur J Higgins Director 26,741 $7.73M -$4.67M 80 2025-04-02
7 Victoria Reich Director 26,376 $7.62M -$5.01M 89 2026-04-02
8 David MacLennan Director 26,334 $7.61M $2.55M 76 2026-10-02
9 Laurie M Marsh EVP - HUMAN RESOURCES 25,809 $7.46M -$11.20M 35 2025-02-21
10 Larry L Berger EVP & CHIEF TECHNICAL OFFICER 25,623 $7.40M -$25.13M 59 2025-02-27
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

ECL Proposed Insider Sales (Form 144)

Latest: 2026-08-18
Last 30d: 0 filings  ·  Last 90d: 4 filings · $7.7M notice value · 4 unique filers

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Christophe Beck (1, $4.9M) · Cook Gregory B (1, $1.3M) · KIRKLAND SCOTT D. (1, $952K) · BRADWAY JENNIFER J. (1, $500K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-08-18 Christophe Beck Officer 17,862 $4.93M 2026-08-18 U.S. Bank N.A. — EDGAR
2026-08-11 Cook Gregory B Officer 4,567 $1.30M 2026-08-11 Morgan Stanley Smith Barney LLC … — EDGAR
2026-08-07 BRADWAY JENNIFER J. Officer 1,765 $500.3K 2026-08-07 Morgan Stanley Smith Barney LLC … — EDGAR
2026-07-30 KIRKLAND SCOTT D. Officer 3,357 $952.4K 2026-07-30 Morgan Stanley Smith Barney LLC … — EDGAR
2026-06-09 Darrell R. Brown Officer 10,000 $2.57M 2026-06-09 Morgan Stanley Smith Barney LLC … — EDGAR
2026-05-27 Suzanne M. Vautrinot Director 1,004 $255.2K 2026-05-27 Wells Fargo Clearing Services — EDGAR
2026-02-26 Gregory B. Cook Officer 3,519 $1.08M 2026-02-26 Morgan Stanley Smith Barney LLC … — EDGAR
2026-02-25 Tracy B. McKibben Director 1,265 $389.8K 2026-02-25 Morgan Stanley Smith Barney LLC … — EDGAR
2026-02-24 Christophe Beck Officer, Director 20,000 $6.11M 2026-02-24 Morgan Stanley Smith Barney LLC … — EDGAR
2026-02-17 Nicholas J. Alfano Officer 9,501 $2.84M 2026-02-17 Morgan Stanley Smith Barney LLC … — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-29 0001104659-26-068276 EDGAR
2026-05-11 0001104659-26-058710 EDGAR
2026-04-28 0001104659-26-049822 EDGAR
2026-04-15 0001104659-26-043821 EDGAR
2026-03-27 0001104659-26-035705 EDGAR
2026-03-20 0001104659-26-032446 EDGAR
2026-02-25 0001104659-26-019742 EDGAR
2026-02-23 0001104659-26-018605 EDGAR
2026-02-10 0001104659-26-012358 EDGAR
2025-10-28 0001104659-25-102859 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-23 0001104659-26-018357 EDGAR
2025-02-21 0001558370-25-001263 EDGAR
2024-02-23 0001558370-24-001581 EDGAR
2023-02-24 0001558370-23-001969 EDGAR
2022-02-25 0001558370-22-002059 EDGAR
2021-02-26 0001558370-21-001916 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-07 0001104659-26-056737 EDGAR
2025-10-30 0001104659-25-104386 EDGAR
2025-08-07 0001558370-25-010768 EDGAR
2025-05-08 0001558370-25-006969 EDGAR
2024-10-31 0001558370-24-014051 EDGAR
2024-08-02 0001558370-24-010647 EDGAR
2024-05-02 0001558370-24-006535 EDGAR
2023-11-02 0001558370-23-017421 EDGAR
2023-08-03 0001558370-23-013204 EDGAR
2023-05-04 0001558370-23-008089 EDGAR
ETF Holders
330 ETFs hold ECL
25 shown · $10.25B total exposure · 0.17% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.09% $2.2B — 2026-09-30
2 VOO Vanguard S&P 500 ETF Vanguard 0.11% $1.8B — 2026-09-30
3 IVV iShares Core S&P 500 ETF iShares (BlackRock) 0.11% $966.2M $890.0B 2026-10-14
4 SPY State Street® SPDR® S&P 500® ETF Trust SPDR (State Street) 0.11% $884.8M $812.7B 2026-10-14
5 VUG Vanguard Morningstar Growth ETF Vanguard 0.21% $814.1M — 2026-09-30
6 JEPI JPMorgan Equity Premium Income ETF JPMorgan 1.12% $512.9M $45.9B 2026-10-15
7 XLB State Street® Materials Select Sector SPDR® ETF SPDR (State Street) 5.13% $407.2M $7.9B 2026-10-14
8 VIG Vanguard Dividend Appreciation ETF Vanguard 0.31% $391.9M — 2026-09-30
9 VAW Vanguard Materials ETF Vanguard 4.84% $218.5M — 2026-09-30
10 RSP Invesco S&P 500 Equal Weight ETF Invesco 0.21% $209.0M — 2026-10-14
11 SPYM State Street® SPDR® Portfolio S&P 500® ETF SPDR (State Street) 0.11% $199.8M $183.2B 2026-10-14
12 NOBL ProShares S&P 500 Dividend Aristocrats ETF ProShares 1.56% $178.9M — 2026-10-15
13 PHO Invesco Water Resources ETF Invesco 8.37% $160.8M — 2026-10-14
14 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.19% $159.5M $83.8B 2026-10-14
15 MGK Vanguard Morningstar Mega Cap Growth ETF Vanguard 0.43% $150.2M — 2026-09-30
16 QUAL iShares MSCI USA Quality Factor ETF iShares (BlackRock) 0.30% $147.3M $49.0B 2026-10-14
17 IVE iShares S&P 500 Value ETF iShares (BlackRock) 0.24% $120.6M $49.9B 2026-10-14
18 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.12% $106.0M — 2026-10-14
19 SDY State Street® SPDR® S&P® Dividend ETF SPDR (State Street) 0.50% $105.0M $21.1B 2026-10-14
20 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.10% $93.6M $97.1B 2026-10-14
21 SPYV State Street® SPDR® Portfolio S&P 500® Value ETF SPDR (State Street) 0.24% $89.4M $36.7B 2026-10-14
22 IYM iShares U.S. Basic Materials ETF iShares (BlackRock) 6.43% $85.8M $1.3B 2026-10-14
23 VV Vanguard Morningstar Large-Cap ETF Vanguard 0.11% $81.6M — 2026-09-30
24 DGRO iShares Core Dividend Growth ETF iShares (BlackRock) 0.17% $74.5M $43.8B 2026-10-14
25 ESGU iShares ESG Aware MSCI USA ETF iShares (BlackRock) 0.40% $72.8M $18.1B 2026-10-14
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
38.78
TTM Diluted EPS
$7.45
TTM Revenue
$16.84B
TTM Net Income
$2.12B
TTM Op. Cash Flow
$3.06B
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$4.42B$534.90M$1.90$729.50M
Q1 '262026-03-31$4.07B$432.60M$1.52$445.90M
Q4 '252025-12-31$4.20B$563.90M$1.98$1.09B
Q3 '252025-09-30$4.17B$585.00M$2.05$791.30M
Q2 '252025-06-30$4.03B$524.20M$1.84$701.80M
Q1 '252025-03-31$3.69B$402.50M$1.41$369.40M
Q4 '242024-12-31$4.01B$472.90M$1.65$766.70M
Q3 '242024-09-30$4.00B$736.50M$2.58$786.70M
Q2 '242024-06-30$3.99B$490.90M$1.71$611.10M
Q1 '242024-03-31$3.75B$412.10M$1.43$649.40M
Q4 '232023-12-31$3.94B$405.20M$1.41$852.50M
Q3 '232023-09-30$3.96B$404.00M$1.41$787.70M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-06
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
38.78
P/B
8.14
P/S
4.87
EV/EBITDA
23.92
EV/Sales
5.28
ROE
21.0%
ROA
7.1%
Div Yield
0.98%
FCF Yield
3.72%
Debt/Equity
1.18
Current Ratio
—
Market Cap
$82.08B
as of 2026-10-16
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
5.37M
SI % of Float
2.24%
Days to Cover
4.39
Short Vol Ratio
25.4%
Free Float
239.77M
Float %
85.5%
Short interest 2026-09-30 • Short volume 2026-10-16 • Float 2026-09-23